发明人冯建国,沈红梅,林芳. "一种替沃扎尼杂质11的合成方法" [P]. 中国发明专利, 专利号 CN 115097015 A, 授权公告日 2024-03-20.
发明人林芳,黄志刚,陈志强. "Method for the Synthesis of Tivozanib Impurity 11" [P]. 中国发明专利, 专利号 CN 117087647 B, 授权公告日 2020-04-01.
发明人孙丽萍,钱学锋,赵玉洁. "A Process for Preparing High-Purity Tivozanib Impurity 11" [P]. 中国发明专利, 专利号 CN 108898576 B, 授权公告日 2019-02-13.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 替沃扎尼杂质11 in Pharmaceutical Formulations". Molecules, 2016, 175, (8), 2399-2415.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 替沃扎尼杂质11 as an Impurity". Biomed. Chromatogr., 2012, 2118, 2255-2258.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of Tivozanib Impurity 11 Using HRMS and NMR". Anal. Chem., 2017, 1799, (11), 3745-3755.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate 替沃扎尼杂质11 Profile in Drug Substances According to ICH Guidelines". Food Chem., 2017, 1100, (6), 4351-4376.